Drugs / CBT102-A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05948020 | Sep → Nov 2023 | phenylketonuria | Children's Hospital of Fudan University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBT102-A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05948020 ↗ |
| Route | Oral | “Orally CBT102-A will be supplied by CommBio Therapeutics.” NCT05948020 ↗ |